You are here: Industry Insights > Prostate Cancer

News List

Taking a standard prostate cancer drug with food boosts impact europeanpharmaceuticalreview
April 04, 2018
By taking Zytiga with a low-fat meal could decrease the daily dose and prevent digestive issues…
USFDA grants priority to XTANDI's sNDA biospectrumasia
March 21, 2018
When approved, the sNDA would expand the indication of XTANDI to include men with non-metastatic Castration-Resistant Prostate Cancer
FDA Grants Priority Review for Prostate Cancer Treatment biospace
March 21, 2018
Pfizer and Astellas Pharmaceuticals Say to Apply for Supplementary New Drugs for US Food and Drug Administration
NHS trials "world-leading" initiative to cut prostate cancer diagnoses to just days pharmafile
March 06, 2018
The NHS has revealed plans to cut the average diagnosis times for prostate cancer from six weeks to less than one week by trialling a “world-leading” approach which leverages a new, more accurate scanning method.
Brexit may disrupt medicines supply, warns British alliance pharmaceutical-technology
January 31, 2018
The alliance cited an example that around 120,000 prostate cancer patients across Europe might be affected if Brexit negotiations fail to secure a future collaboration on regulation and trade of medicines and medical devices.
Dietary fat, changes in fat metabolism may promote prostate cancer metastasis europeanpharmaceuticalreview
January 17, 2018
Researchers have shed new light on the genetic mechanisms that promote metastasis and implicated the typical Western high-fat diet as a key environmental factor…
Tapeworm drug fights prostate cancer europeanpharmaceuticalreview
November 17, 2017
A Norwegian study shows that NTZ contains a substance that can kill prostate and colon cancer…
Pfizer receives prostate cancer drug boost with trial results pharmafile
September 18, 2017
Pfizer, and its partner Astellas Pharma, received a major boost to its plans for prostate cancer treatment, Xtandi, by announcing it has received positive data for treating the condition at an early stage.
Exosome Diagnostics, CareFirst partner to speed up coverage for diagnostic tests fiercebiotech
August 28, 2017
The partnership with Exosome Diagnostics is part of CareFirst's HealthWorx program, under which the insurance provider works with early-stage companies to accelerate health plan coverage of their products.
Recipharm and LIDDS establish industrial manufacturing capabilities for a novel prostate cancer prod cphi-online
July 21, 2017
GMP Manufacturing line industrialised according to a unique process invented by LIDDS, involving the installation of novel equipment that is new to the pharmaceutical industry.

Previous page 1 2 3 4 5 6 7 8 9 10 Next page